Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 10/20 | 0.47 |
| ▸ | CA2 | P00918 | 10/20 | 0.47 |
| ▸ | CA9 | Q16790 | 9/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345885 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL5015857 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL6061185 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL8085071 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4193998 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL2194649 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL10731635 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL974536 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL10725263 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL3088278 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 701 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119804738-A | Detection method for genotoxic impurities in dabigatran etexilate mesylate | 核工业北京化工冶金研究院 | 2025-04-11 | — | — | CN | claimed |
| CN-113933400-B | Detection method of genotoxic impurities in dabigatran etexilate bulk drug or preparation | 石药集团恩必普药业有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-113933400-A | Method for detecting genotoxic impurities in dabigatran etexilate bulk drug or preparation | 石药集团恩必普药业有限公司 | 2022-01-14 | — | — | CN | claimed |
| CN-109942436-B | Method for preparing N, N-dialkyl aniline compound by alkylation of alkyl p-toluenesulfonate | 大连理工大学 | 2021-06-22 | — | — | CN | claimed |
| CN-110357889-A | Protein degradation target compound, its antitumor application thereof, wherein mesosome and intermediate application | 上海科技大学 | 2019-10-22 | — | — | CN | claimed |
| CN-106632358-A | Method for preparing lurasidone hydrochloride intermediate | 北京万全德众医药生物技术有限公司 | 2017-05-10 | — | — | CN | claimed |
| WO-2008147472-A1 | ETHERS OF BISANHYDROHEXITOLS | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2008-12-04 | — | — | WO | claimed |
| US-20080021209-A1 | Ethers of bisanhydrohexitols | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2008-01-24 | — | — | US | claimed |
| EP-0588906-B2 | PROCESSIBLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE AND CONDUCTIVE PRODUCTS FORMED THEREFROM | DUPONT DISPLAYS INC (US) | 2003-06-18 | — | — | EP | claimed |
| EP-0588906-B1 | PROCESSIBLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE AND CONDUCTIVE PRODUCTS FORMED THEREFROM | UNIAX CORP (US) | 2000-08-02 | — | — | EP | claimed |
| EP-0588906-A4 | PROCESSIBLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE AND CONDUCTIVE PRODUCTS FORMED THEREFROM | UNIAX CORP (US) | 1994-08-24 | — | — | EP | claimed |
| EP-0588906-A1 | PROCESSIBLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE AND CONDUCTIVE PRODUCTS FORMED THEREFROM | UNIAX CORPORATION (US) | 1994-03-30 | — | — | EP | claimed |
| WO-1992022911-A1 | PROCESSIBLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE AND CONDUCTIVE PRODUCTS FORMED THEREFROM | UNIAX CORPORATION (US) | 1992-12-23 | — | — | WO | claimed |
| US-12637540-B2 | Resin produced by polycondensation, and resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-05-26 | — | — | US | disclosed |
| WO-2026105863-A1 | BIFUNCTIONAL COMPOUND AND METHOD FOR PRODUCING BIFUNCTIONAL COMPOUND | 三菱瓦斯化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026105862-A1 | BIFUNCTIONAL COMPOUND, COMPOUND, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING BIFUNCTIONAL COMPOUND | 三菱瓦斯化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-4012397-A | 2-Benzoyl-3-amino-pyridines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-03-15 | — | — | US | disclosed |
| US-4004012-A | 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones | STERLING DRUG INC. (US) | 1977-01-18 | — | — | US | disclosed |
| US-3969361-A | 2-Benzoyl-3-amino-pyridines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-07-13 | — | — | US | disclosed |
| US-3960890-A | CONTROL OF ECTOPARASITES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637540-B2 | Resin produced by polycondensation, and resin composition | TAF1, TAF5, PUF60 | RECQL 3195/4885GLA 2317/4885HPGD 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.